MedTrace Logo

Effect of Right Ventricular Lead Position on Defibrillation Threshold

NCT02844127 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-09-19

No results posted yet for this study

Summary

The purpose of this study is to determine how the position of the right ventricular (RV) coil of an implantable cardioverter defibrillator (apex versus septum) affects the defibrillation threshold; specifically, can defibrillator threshold be improved by implantation site selection.

Conditions

  • Ventricular Tachycardia
  • Ventricular Fibrillation

Interventions

PROCEDURE

Implantable Cardioverter Defibrillator (ICD)

Patients will receive an Implantable Cardioverter Defibrillator (ICD), with the leads implanted in either the apex or the septum as the first location. After defibrillation threshold is determined, the leads position will be changed to the second location and DFT will be determined again.

Sponsors & Collaborators

  • Abbott Medical Devices

    collaborator INDUSTRY

  • OhioHealth

    lead OTHER

Principal Investigators

  • Seth J Rials, MD, PhD · OhioHealth

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-04-04
Completion
2017-04-04

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02844127 on ClinicalTrials.gov